floxacillin has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alffenaar, JWC; Brüggemann, RJM; Dekkers, BGJ; Groeneveld, GH; Henriet, SSV; Lashof, AMLO; Muilwijk, EW; Russel, FGM; van de Veerdonk, F; van der Hoeven, J; Verweij, PE; Witjes, B | 1 |
| Hockertz, S; Lohmann-Matthes, ML; Roesler, J; Vogt, B | 1 |
2 other study(ies) available for floxacillin and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Interactions; Female; Floxacillin; Granulomatous Disease, Chronic; Humans; Invasive Fungal Infections; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole; Young Adult | 2017 |
Staphylococci surviving intracellularly in phagocytes from patients suffering from chronic granulomatous disease are killed in vitro by antibiotics encapsulated in liposomes.
Topics: Anti-Bacterial Agents; Drug Carriers; Floxacillin; Granulomatous Disease, Chronic; Humans; Liposomes; Neutrophils; Phagocytes; Phagocytosis; Rifampin; Staphylococcus | 1991 |